$SCL

Stepan has raised its dividend 58 years in a row as March payout set

Stepan Company (NYSE: SCL) has declared a quarterly cash dividend of $0.395 per share, payable on March 13, 2026, to shareholders of record on March 2, 2026. This marks the 58th consecutive year the company has increased its dividend, following a $0.010 per share increase in Q4 2025. Despite this consistent increase, the stock experienced a significant negative market reaction, declining 20.38% on the day this news was published, resulting in a $352 million reduction in the company's valuation.

Original reporting
Published Apr 20, 2026, 11:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 21, 2026, 12:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stepan has raised its dividend 58 years in a row as March payout set — source image
Decision brief

The 30-second read

$SCLBearishLow
01

Why it matters

The immediate market reaction was negative, possibly due to profit-taking, sector concerns, or broader market declines.

02

Market read

While the dividend increase is a positive signal, the recent stock decline overshadows this, indicating caution for traders.

03

What to watch

Potential broader market corrections or sector-specific issues influencing the stock price.

Timing: short-term

Background

Stepan Company has a long history of dividend increases, reflecting stable cash flows and shareholder commitment.

Company-level read

Ticker impact

$SCLBearishMedium confidence
Context

Primary focus due to recent dividend increase and significant stock decline.

Expected impact

short-term decline of approximately 20-25%, with potential stabilization or recovery over the medium term.

Evidence & confidence

The substantial stock drop suggests negative market sentiment, possibly due to underlying concerns or broader market conditions. The dividend increase alone is unlikely to drive immediate positive price movement given the current decline.

Market effects

Possible negative sentiment in the chemical manufacturing sector due to the stock decline.

Limited, primarily affecting investors in the U.S. market.

negligible, as the impact appears localized and company-specific.

Counterpoint

The dividend increase signals strong long-term fundamentals; the stock decline may be a temporary overreaction.

Key entities

  • Stepan Company

    A chemical manufacturing firm with a history of consistent dividend increases.

Related articles

$SCLMed

Stepan Company Q2 2026 Earnings Call Summary

Strategic Performance Drivers Adjusted EBITDA growth of 45% was driven by a combination of 6% organic volume growth, disciplined pricing execution, and ramping productivity gains. Surfactant performance benefited from broad-based demand across all end markets, specifically led by industrial cleaning, laundry, and oil field sectors. Margin recovery was achieved through the rigorous application of contractual pass-through mechanisms and pricing actions to offset fluctuating raw material costs.

$SCLMedAI 8/10

Stepan Reports Second Quarter 2026 Results

Stepan (NYSE: SCL) reported Q2 2026 net income of $22.9M, up 102% year over year, and adjusted net income of $27.1M, up 126%. Adjusted EBITDA rose 45% to $74.4M. Net sales increased 15% to $684.1M, with organic volume up 6%. Free cash flow was -$15.0M due to working capital. The company plans to cut about 100 salaried roles under Project Catalyst and expects full-year restructuring charges of $75.0M-$80.0M.

$SCLMed

STEPAN CO (SCL): Results of Operations and Financial Condition

STEPAN CO (SCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d139905dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Stepan Reports Second Quarter 2026 Results Northbrook, Illinois, July 29, 2026 — Stepan Company (NYSE: SCL) today reported: Second Quarter 2026 Highlights • Reported net income was $22.9 million, up 102% versus the prior ye

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

$SCLHighAI 9/10

Daily NZX update, Wednesday, May 27, 2026

The NZX50 rose 0.7% to extend gains to 3.1% over five days and 3.1% for the month (still down 2.0% over six months; up 4.6% YoY). Kathmandu Holdings jumped 14% and KMD reported Q3 FY26 sales +5.2% YoY and gross margin 58.2% (+258 bps). Vista Group gained 4% on a new five-year Cinemex deal; PaySauce revenue rose 3% to $9.2m.

$LMTMed

What is the Patriot missile system and why are supplies depleted worldwide?

Reuters explains the U.S. Patriot mobile air defense system, built by Raytheon Technologies, and its PAC-2 and PAC-3 interceptor variants. Demand has risen as Russia’s strikes in Ukraine and the Middle East conflict have depleted interceptor stocks. CSIS estimates about 65% of U.S. interceptors were used Feb-July, leaving under 850. Lockheed received a contract up to $58.6B.